Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7525824 | 1.00 | CETP (0.42) | CETPTSHRPKM | |
| SCHEMBL7697889 | 0.81 | CETP (0.43) | CETPTSHRPKM | |
| SCHEMBL7534521 | 0.80 | CETP (0.39) | CETPPKM | |
| SCHEMBL7534523 | 0.80 | CETP (0.39) | CETPPKM | |
| Hydrochloric Acid SCHEMBL27806815 | 0.79 | CETP (0.42) | CETPTSHRPKM | |
| SCHEMBL469203 | 0.77 | — | — | |
| SCHEMBL7312976 | 0.77 | — | — | |
| SCHEMBL765946 | 0.77 | — | — | |
| SCHEMBL15354749 | 0.77 | CETP (0.40) | CETPTSHRPKM | |
| SCHEMBL7530274 | 0.77 | CETP (0.40) | CETPTSHRPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110319378-A1 | PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER | AMGEN INC. (US) | 2011-12-29 | — | — | US | disclosed |
| EP-0937765-B1 | Ferrielectric liquid crystal compound | MITSUBISHI GAS CHEMICAL CO (JP) | 2002-05-29 | — | — | EP | disclosed |
| EP-0842915-B1 | Optically active alcohol and process for the production thereof | MITSUBISHI GAS CHEMICAL CO (JP) | 2002-03-27 | — | — | EP | disclosed |
| US-6128065-A | 2 OR 3-FLUORO SUBSTITUTED OR UNSUBSTITUTED 4-(1-TRIFLUOROMETHYL-4-METHYL-PENTYL OR HEXYLOXYCARBONYL)PHENYL-4'-N-ALKYLBIPHENYL-4-CARBOXYLATE CONTAINING ASYMMETRIC CARBON ATOM | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2000-10-03 | — | — | US | disclosed |
| EP-0937765-A1 | Ferrielectric liquid crystal compound | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1999-08-25 | — | — | EP | disclosed |
| EP-0842915-A2 | Optically active alcohol and process for the production thereof | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1998-05-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319378-A1 | PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER | MDM2, TP53, CDKN1A | CETP 4613/4885TSHR 4432/4885PKM 1602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.